{"title":"CD-g-CS纳米颗粒增强抗生素治疗木糖葡萄球菌感染","authors":"Si-Di Zheng, Zhi-Yun Zhang, Jin-Xin Ma, Qian-Wei Qu, Bello-Onaghise God'spowe, Yue Qin, Xue-Ying Chen, LU Li, Dong-Fang Zhou, Wen-Ya Ding, Yan-Hua Li","doi":"10.1111/1751-7915.13870","DOIUrl":null,"url":null,"abstract":"<p><i>Staphylococcus xylosus</i> (<i>S. xylosus</i>)-induced cow mastitis is an extremely serious clinical problem. However, antibiotic therapy does not successfully treat <i>S. xylosus</i> infection because these bacteria possess a strong biofilm formation ability, which significantly reduces the efficacy of antibiotic treatments. In this study, we developed ceftiofur-loaded chitosan grafted with β-cyclodextrins (CD-g-CS) nanoparticles (CT-NPs) using host–guest interaction. These positively charged nanoparticles improved bacterial internalization, thereby significantly improving the effectiveness of antibacterial treatments for planktonic <i>S. xylosus</i>. Moreover, CT-NPs effectively inhibited biofilm formation and eradicated mature biofilms. After mammary injection in a murine model of <i>S. xylosus</i>-induced mastitis, CT-NPs significantly reduced bacterial burden and alleviated inflammation, thereby achieving optimized therapeutic efficiency for <i>S. xylosus</i> infection. In conclusion, this treatment strategy could improve the efficiency of antibiotic therapeutics and shows great potential in the treatment of <i>S. xylosus</i> infections.</p>","PeriodicalId":49145,"journal":{"name":"Microbial Biotechnology","volume":"15 2","pages":"535-547"},"PeriodicalIF":4.8000,"publicationDate":"2021-06-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1111/1751-7915.13870","citationCount":"2","resultStr":"{\"title\":\"CD-g-CS nanoparticles for enhanced antibiotic treatment of Staphylococcus xylosus infection\",\"authors\":\"Si-Di Zheng, Zhi-Yun Zhang, Jin-Xin Ma, Qian-Wei Qu, Bello-Onaghise God'spowe, Yue Qin, Xue-Ying Chen, LU Li, Dong-Fang Zhou, Wen-Ya Ding, Yan-Hua Li\",\"doi\":\"10.1111/1751-7915.13870\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><i>Staphylococcus xylosus</i> (<i>S. xylosus</i>)-induced cow mastitis is an extremely serious clinical problem. However, antibiotic therapy does not successfully treat <i>S. xylosus</i> infection because these bacteria possess a strong biofilm formation ability, which significantly reduces the efficacy of antibiotic treatments. In this study, we developed ceftiofur-loaded chitosan grafted with β-cyclodextrins (CD-g-CS) nanoparticles (CT-NPs) using host–guest interaction. These positively charged nanoparticles improved bacterial internalization, thereby significantly improving the effectiveness of antibacterial treatments for planktonic <i>S. xylosus</i>. Moreover, CT-NPs effectively inhibited biofilm formation and eradicated mature biofilms. After mammary injection in a murine model of <i>S. xylosus</i>-induced mastitis, CT-NPs significantly reduced bacterial burden and alleviated inflammation, thereby achieving optimized therapeutic efficiency for <i>S. xylosus</i> infection. In conclusion, this treatment strategy could improve the efficiency of antibiotic therapeutics and shows great potential in the treatment of <i>S. xylosus</i> infections.</p>\",\"PeriodicalId\":49145,\"journal\":{\"name\":\"Microbial Biotechnology\",\"volume\":\"15 2\",\"pages\":\"535-547\"},\"PeriodicalIF\":4.8000,\"publicationDate\":\"2021-06-28\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.1111/1751-7915.13870\",\"citationCount\":\"2\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Microbial Biotechnology\",\"FirstCategoryId\":\"5\",\"ListUrlMain\":\"https://onlinelibrary.wiley.com/doi/10.1111/1751-7915.13870\",\"RegionNum\":2,\"RegionCategory\":\"生物学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"BIOTECHNOLOGY & APPLIED MICROBIOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Microbial Biotechnology","FirstCategoryId":"5","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1111/1751-7915.13870","RegionNum":2,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"BIOTECHNOLOGY & APPLIED MICROBIOLOGY","Score":null,"Total":0}
CD-g-CS nanoparticles for enhanced antibiotic treatment of Staphylococcus xylosus infection
Staphylococcus xylosus (S. xylosus)-induced cow mastitis is an extremely serious clinical problem. However, antibiotic therapy does not successfully treat S. xylosus infection because these bacteria possess a strong biofilm formation ability, which significantly reduces the efficacy of antibiotic treatments. In this study, we developed ceftiofur-loaded chitosan grafted with β-cyclodextrins (CD-g-CS) nanoparticles (CT-NPs) using host–guest interaction. These positively charged nanoparticles improved bacterial internalization, thereby significantly improving the effectiveness of antibacterial treatments for planktonic S. xylosus. Moreover, CT-NPs effectively inhibited biofilm formation and eradicated mature biofilms. After mammary injection in a murine model of S. xylosus-induced mastitis, CT-NPs significantly reduced bacterial burden and alleviated inflammation, thereby achieving optimized therapeutic efficiency for S. xylosus infection. In conclusion, this treatment strategy could improve the efficiency of antibiotic therapeutics and shows great potential in the treatment of S. xylosus infections.
期刊介绍:
Microbial Biotechnology publishes papers of original research reporting significant advances in any aspect of microbial applications, including, but not limited to biotechnologies related to: Green chemistry; Primary metabolites; Food, beverages and supplements; Secondary metabolites and natural products; Pharmaceuticals; Diagnostics; Agriculture; Bioenergy; Biomining, including oil recovery and processing; Bioremediation; Biopolymers, biomaterials; Bionanotechnology; Biosurfactants and bioemulsifiers; Compatible solutes and bioprotectants; Biosensors, monitoring systems, quantitative microbial risk assessment; Technology development; Protein engineering; Functional genomics; Metabolic engineering; Metabolic design; Systems analysis, modelling; Process engineering; Biologically-based analytical methods; Microbially-based strategies in public health; Microbially-based strategies to influence global processes